LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required

Latent Membrane Protein 1 and the B Lymphocyte-A Complex Relationship

(2014) Laura L. Stunz et al.   CRITICAL REVIEWS IN IMMUNOLOGY

Gene Expression Profiling Identifies IRF4-Associated Molecular Signatures in Hematological Malignancies

(2014) Ling Wang et al.   PLoS One

Interferon Regulatory Factor 4 Is Activated through c-Src-Mediated Tyrosine Phosphorylation in Virus-Transformed Cells

(2013) L. Wang et al.   JOURNAL OF VIROLOGY

The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8

(2013) Shuvomoy Banerjee et al.   PLoS Pathogens

Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model

(2012) Baochun Zhang et al.   CELL

Src Kinase and Syk Activation Initiate PI3K Signaling by a Chimeric Latent Membrane Protein 1 in Epstein-Barr Virus (EBV)+ B Cell Lymphomas

(2012) Olivia Hatton et al.   PLoS One

The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)

(2012) Christopher W. Dawson et al.   SEMINARS IN CANCER BIOLOGY

IRF4 mutations in chronic lymphocytic leukemia

(2011) V. Havelange et al.   BLOOD

IRF7: activation, regulation, modification and function

(2011) S Ning et al.   GENES AND IMMUNITY

OX40 Complexes with Phosphoinositide 3-Kinase and Protein Kinase B (PKB) To Augment TCR-Dependent PKB Signaling

(2011) T. So et al.   JOURNAL OF IMMUNOLOGY

Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression

(2011) L. Wang et al.   JOURNAL OF VIROLOGY

Malignant pirates of the immune system

(2011) Lixin Rui et al.   NATURE IMMUNOLOGY

Chronic Viral Infection and Primary Central Nervous System Malignancy

(2010) Robert Saddawi-Konefka et al.   Journal of Neuroimmune Pharmacology

Identification of activated Tnk1 kinase in Hodgkin's lymphoma

(2010) T-L Gu et al.   LEUKEMIA

IRF4: Immunity. Malignancy! Therapy?

(2009) A. L. Shaffer et al.   CLINICAL CANCER RESEARCH

IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?

(2009) Partha S. Biswas et al.   IMMUNOLOGICAL REVIEWS

Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition

(2009) J. R. St-Germain et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interferon Regulatory Factor 4 Is Involved in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes

(2008) D. Xu et al.   JOURNAL OF VIROLOGY

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

(2008) A L Feldman et al.   LEUKEMIA

TRAF6 and the Three C-Terminal Lysine Sites on IRF7 Are Required for Its Ubiquitination-Mediated Activation by the Tumor Necrosis Factor Receptor Family Member Latent Membrane Protein 1

(2008) S. Ning et al.   MOLECULAR AND CELLULAR BIOLOGY

IRF4 addiction in multiple myeloma

(2008) Arthur L. Shaffer et al.   NATURE

EBV-Associated Lymphoproliferative Disorders: Classification and Treatment

(2008) A. Carbone et al.   ONCOLOGIST

Multiple roles of LMP1 in Epstein-Barr virus induced immune escape

(2008) J.M. Middeldorp et al.   SEMINARS IN CANCER BIOLOGY